Pharmaceutical Industries and Education In India PDF / PPT

Save (0)
Close

Recommended

Description

Pharmaceutical Industries and
Education

In India

 

Learning objectives

At the end of this lecture, the student will be able to:

Explain the growth of pharmaceutical industries in India

Discuss the growth of pharmaceutical eduaction in India

 

The Indian Pharmaceutical Industry

 The Indian pharmaceuticals industry has grown from a mere $0.3billion in 1980, to $12

billion in 2012.

 Branded generics dominate the market, making up 70-80% of it.

 The local companies enjoy a dominant position due to their development capabilities

and early investment, as from 1970 to 2005, Indian law only recognized process patents

and not product patents, which many companies took advantage of.

 The price of drugs is very low, due to intense competition. While India is 10th globally in

terms of value, it is 3rd in term of volume of drugs produced.

 

The Indian Set-Up

 The Indian pharmaceutical sector is highly fragmented, with more than 20,000

registered companies, with the top 250 companies controlling 70% of the market.

These companies can currently meet about 70% of the countries demands for drugs;

this is mainly through the Maharashtra and Gujarat regions, which account for 45% of

the total number of pharmaceutical manufacturing units in India.

 

SWOT Analysis of Indian Pharmaceutical Industry
Strengths Weaknesses Opportunities Threats

•Low cost skilled manpower •Stringent pricing regulations •Increase in per capita income •Other low cost countries

•Access to large pool of highly •Poor transport and medical •Global demand for generics affecting demand

trained scientists infrastructure rising •Government regulations ever

•Strong marketing and •Lack of data protection •Increasing population with changing

distribution network • Competitive environment more inactive lifestyle •Expanding of Drugs Price

•Proven track record in design •Poor health insurance coverage •Increasing health insurance Control Order

of high technology •Production of low quality drugs sector •Lack of investment in

manufacturing devices tarnishes image of industry •Significant investment from infrastructure

•Low cost of innovation, abroad MNCs •Wage inflation

manufacturing and operations •Low investment in innovative •Medical tourism •R&D restricted by lack of

R&D •Cheap, diverse clinical trials animal testing and outdated

•Global outsourcing hub due to patient office

low cost of skilled labor •Counterfeiting threat

 

www.DuloMix.com 6

 

Growth Factors for Indian Market

 Population Growth
 Socio Economic Changes and Urbanization
 Increasing acceptability of modern medicine
 More affordable drugs
 More accessibility to drugs and medical care
 Cheap production cost
 Government regulations targeting growth and competitive market
 Contract R&D
 Medical Tourism

 

Key Players

Company Net Sales (30th Employees
July 2013 $Bn)

Cipla 1.39 20,000

Dr Reddy’s 1.14 16,300
Laboratories

Ranbaxy Labs 1.07 14,600

Aurobindo 0.92 8,635
Pharma

Lupin Ltd 0.91 11,355

Sun Pharma 0.68 11,200

Novartis India 0.14 4,500 (115,000
Worldwide)

 

International Players

Company Net Employees
Sales

(2012 $
Bn)

Johnson & 67.2 117,000
Johnson
(USA)

Pfizer (USA) 58.9 91,000

Novartis 56.7 115,000
(Switzerland)

Roche 47.8 80,000
(Switzerland)

Merck (USA) 47.3 86,000

Sanofi 46.4 113,000
(French)

GlaxoSmithK 39.9 97,000
line (UK)

 

Early Pharmacy Education
➢ 1860 – Madras Medical College – Method of making up prescriptions and compounding
– 2 year Diploma in Pharmacy
➢1937- Andhra University, Visakhapatnam
➢ Compounder Courses in Bengal, Mumbai, UP
Modern Pharmacy Education
➢ 1934 – BHU, Varanasi – B.Pharm – Prof. M.L. Schroff – Father of Modern Pharmacy
Education in India
➢ Andhra University, Visakhapatnam
➢Nagpur University
➢Madras Medical College
➢ Dept. of Chemical Technology, University of Bombay
➢Punjab University
➢BITS, Pilani
➢University of Saugar

 

Post Graduate Pharmacy Education
➢ 1940 – BHU, Varanasi – M.Pharm

➢ Andhra University, Visakhapatnam

➢Nagpur University

➢Madras Medical College

➢ Dept. of Chemical Technology, University of Bombay

➢Punjab University

➢BITS, Pilani

➢University of Saugar

➢S.M.S. Medical College Jaipur

➢ L.M. College of Pharmacy, Ahmedabad

 

Present Scenario in Pharmacy Education
➢D.PHARM

➢M.PHARM

➢ PHARM.D

➢ PHARM.D – POST BACCLAURATE

➢ Ph.D

Regulatory Bodies in Pharmacy Education

❖ Pharmacy Council of India (PCI)

❖ All India Council for Technical Education (AICTE)

 

Research Institutes
National Institute of Pharmaceutical Education and Research (NIPER)

➢Mohali

➢ Hyderabad

➢Rae Bareilly

➢ Guwahati

➢ Ahmedabad

➢ Hajipur

➢ Kolkatta
Future institutes
National Institute of Pharmaceutical Education and Research, Visakhapatnam
National Institute of Pharmaceutical Education and Research, Nagpur
National Institute of Pharmaceutical Education and Research, Jhalawar
National Institute of Pharmaceutical Education and Research, Chhattisgarh
National Institute of Pharmaceutical Education and Research, Thiruvananthapuram

 

Career Options for Pharmacists

➢ Research & Development – Chemist/Chemical Engineer/Pharmacologist: In new drug

discovery, Process development, F&D,Clinical Trials, Bioequivalance study,Toxicological study,

analytical testing

➢ Production & Manufacturing – Production &Analytical Chemist/Q.C.Chemist/Q.A.Officer

➢Marketing – Marketing Exec.- M.R. involve in pharma sales & supply.

Retail &Hospital Pharmacy – In dispensing & store magt.

➢ Academic – Faculty in pharmacy institute involve in teaching, training & research

➢ Regulatory – In Govt. &Private sector involve in DRA,IPR such as copy right, trademarks etc

➢ Clinical Trials – Pharmacovigilance, drug safety associate, medical writing, medical coding

 

 

Summary
 The local companies enjoy a dominant position due to their development capabilities and

early investment, as from 1970 to 2005, Indian law only recognized process patents and
not product patents

 The price of drugs is very low, due to intense competition. While India is 10th globally in
terms of value, it is 3rd in term of volume of drugs produced

 Population Growth
 Socio Economic Changes and Urbanization
 Increasing acceptability of modern medicine
 More affordably drugs
 More accessibility to drugs and medical care
 Cheap production cost

 

Thank You
www.DuloMix.com